This Month’s Issue
The BioProcess International June 2016 manufacturing theme issue cover is illustrated by a quality assurance technician at AstraZeneca’s facility in Maccleston, UK (www.astrazeneca.com)
This Contract Services supplement showcases how contract services are expanding and specializing, with examples such as biosimilars, cell therapies, development services, and fill and finish.
Once an engineering curiosity and smallscale laboratory technique, continuous bioprocessing has evolved in just a few short years to a topic of intense and increasing interest to most bioprocessors. Critics point to a steep learning/adoption curve, but that is nothing new in biomanufacturing.Andrew Zydney is a distinguished professor of chemical engineering at Pennsylvania State University. He has noted these challenges facing continuous processing: commercially unproven unit operations (especially downstream), a lack of equipment robustness, sterility concerns, and uncertain development timelines…